Piramal Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	5,216	3,889	3,714	1,956	2,281	3,847
Short-Term Investments	2,225	-	-	1	7.1	31.2
Trading Asset Securities	-	195.6	1,447	4,271	504	-
Cash & Short-Term Investments	7,441	4,085	5,160	6,228	2,792	3,878
Cash Growth	82.19%	-20.84%	-17.14%	123.06%	-28.00%	-
Accounts Receivable	19,846	23,757	21,348	18,144	18,086	16,081
Other Receivables	53.7	453.7	171.3	35.6	141.9	447
Receivables	19,900	24,211	21,519	18,179	18,228	16,528
Inventory	27,428	23,127	21,759	16,814	13,888	12,320
Prepaid Expenses	-	791.8	640.2	765.7	695.5	626.6
Restricted Cash	-	1,125	1,112	1,021	913.5	122.3
Other Current Assets	4,762	4,630	4,454	5,347	4,155	3,012
Total Current Assets	59,530	57,970	54,645	48,355	40,672	36,487
Property, Plant & Equipment	52,219	36,267	36,417	44,415	37,157	31,663
Long-Term Investments	2,643	2,711	2,403	2,119	2,168	1,227
Goodwill	11,884	11,482	11,226	11,075	10,305	8,565
Other Intangible Assets	29,836	43,354	43,415	33,382	33,053	27,094
Long-Term Accounts Receivable	-	-	-	18.6	750.6	581.8
Long-Term Deferred Tax Assets	4,527	3,931	3,865	3,493	2,973	2,441
Other Long-Term Assets	1,257	1,061	1,149	2,369	892	939.7
Total Assets	161,894	156,776	153,118	145,226	127,970	108,998
Accounts Payable	18,282	15,338	15,384	11,927	10,264	9,179
Accrued Expenses	170.4	2,991	2,448	2,642	2,141	1,943
Short-Term Debt	-	9,953	11,714	13,023	6,588	3,605
Current Portion of Long-Term Debt	13,986	5,109	9,037	8,189	7,424	2,105
Current Portion of Leases	359.6	370.4	333.1	303.9	184.4	214.9
Current Income Taxes Payable	166.1	96.1	403	35.4	716.6	394.2
Current Unearned Revenue	-	45	19.6	859	452.7	770.3
Other Current Liabilities	8,633	3,760	4,355	1,451	2,564	6,691
Total Current Liabilities	41,597	37,663	43,693	38,431	30,333	24,903
Long-Term Debt	33,169	32,141	24,838	33,835	26,221	23,392
Long-Term Leases	995.5	991.6	1,180	1,019	862	934.1
Long-Term Unearned Revenue	1,819	295.1	238	335.6	460.3	1,427
Pension & Post-Retirement Benefits	-	485.6	322.3	205.9	125.1	67
Long-Term Deferred Tax Liabilities	2,671	2,484	2,292	2,193	1,920	2,225
Other Long-Term Liabilities	904.4	1,462	1,442	1,471	1,082	0.8
Total Liabilities	81,156	75,521	74,004	77,491	61,004	52,948
Common Stock	13,255	13,244	13,230	11,933	11,859	9,946
Additional Paid-In Capital	-	47,372	47,249	38,187	37,252	32,495
Retained Earnings	-	10,493	9,707	9,564	11,589	8,326
Comprehensive Income & Other	67,483	10,146	8,928	8,050	6,267	5,284
Shareholders' Equity	80,738	81,255	79,114	67,735	66,966	56,050
Total Liabilities & Equity	161,894	156,776	153,118	145,226	127,970	108,998
Total Debt	48,510	48,565	47,102	56,371	41,279	30,251
Net Cash (Debt)	-41,069	-44,480	-41,941	-50,143	-38,487	-26,373
Net Cash Per Share	-31.04	-33.43	-32.68	-42.13	-32.65	-42.02
Filing Date Shares Outstanding	1,323	1,324	1,323	1,193	1,186	994.6
Total Common Shares Outstanding	1,323	1,324	1,323	1,193	1,186	994.6
Working Capital	17,933	20,307	10,952	9,924	10,339	11,584
Book Value Per Share	61.03	61.35	59.80	56.76	56.47	56.35
Tangible Book Value	39,019	26,419	24,474	23,278	23,608	20,391
Tangible Book Value Per Share	29.49	19.95	18.50	19.51	19.91	20.50
Land	-	1,792	1,729	1,339	1,300	1,284
Buildings	-	20,380	18,949	15,260	11,996	10,208
Machinery	-	47,560	41,626	36,473	30,662	26,853
Construction In Progress	-	4,891	5,657	8,529	6,732	3,995

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.